HSBC Holdings’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.8M Sell
120,314
-13,057
-10% -$4.2M 0.02% 583
2026
Q2
$64.6M Sell
133,371
-47,926
-26% -$12.7M 0.03% 485
2026
Q1
$19.8M Buy
181,297
+97,576
+117% +$13.9M 0.01% 742
2025
Q4
$14.1M Buy
83,721
+47,081
+128% +$7.88M 0.01% 851
2025
Q3
$7.01M Buy
36,640
+9,766
+36% +$1.61M ﹤0.01% 1056
2025
Q2
$2.44M Buy
26,874
+16,626
+162% +$1.31M ﹤0.01% 1415
2025
Q1
$605K Sell
10,248
-36,217
-78% -$3.35M ﹤0.01% 1990
2024
Q4
$6.28M Buy
46,465
+7,414
+19% +$696K ﹤0.01% 1059
2024
Q3
$2.07M Sell
39,051
-10,576
-21% -$496K ﹤0.01% 1413
2024
Q2
$2.99M Buy
+49,627
New +$3.44M ﹤0.01% 1247

Other funds holding ALAB

HSBC Holdings's ALAB Position: Q3 2026 in Review

HSBC Holdings reduced its Astera Labs (ALAB) stake by 9.8% in Q3 2026, selling an estimated $4.2M and leaving 120,314 shares worth $42.8M. The position accounts for 0.02% of the portfolio, ranked #583.

HSBC Holdings first reported a position in ALAB in Q2 2024 and has held it in 10 quarters since. The position peaked at $64.6M in Q2 2026. 1,005 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • HSBC Holdings held 120,314 shares of Astera Labs worth $42.8M as of Q3 2026.
  • HSBC Holdings sold 13,057 Astera Labs shares in Q3 2026, an estimated $4.2M.
  • Astera Labs made up 0.02% of HSBC Holdings's portfolio in Q3 2026, its #583 holding.
  • HSBC Holdings first reported a position in Astera Labs in Q2 2024 and has held it in 10 quarters since.
  • HSBC Holdings's Astera Labs position peaked at $64.6M in Q2 2026.
  • 1,005 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.